Skip to content
  • Home
  • About Us
    • Our Mission
    • Our Story
    • Leadership
    • Zero-to-IPO
    • Contact Us
  • Cell Therapy
    • Technology
    • Case Study
  • Drug Screening
    • Technology
    • Case Study
  • Nutrition App
    • 3S Features
    • Technology
    • Case Study
  • Our Partners
  • News Room
    • Press Release
  • Career
  • Home
  • About Us
    • Our Mission
    • Our Story
    • Leadership
    • Zero-to-IPO
    • Contact Us
  • Cell Therapy
    • Technology
    • Case Study
  • Drug Screening
    • Technology
    • Case Study
  • Nutrition App
    • 3S Features
    • Technology
    • Case Study
  • Our Partners
  • News Room
    • Press Release
  • Career
繁
繁

Press Release

May 31, 2024


NutrigeneAI Biotech Limited Secured Second Round of Investment from Soul Capital


Mar 27, 2024


NutrigeneAI Biotech Limited Secured First Round of Investment from C Cheng Holdings (01486.HK)


Jan 01, 2024


NutrigeneAI Biotech Limited Approved in HKSTP Ideation Programme, Batch 23


Nov 20, 2023


Founding of NutrigeneAI Biotech Limited: A Total Vascular Solution Brought by Vascular Expertise & Experienced Entrepreneur


Aug 08, 2023


Professor Wong Wing Tak and Team Unveil Groundbreaking Research on Type 2 Cytokines and Angiogenesis in Ischemic Muscle


Google Reviews

Company

  • Home
  • About Us
  • Our Partners
  • News Room
  • Career

Business

  • Nutrition App
  • Cell Therapy
  • Drug Screening

Contact US

Unit 06, 21/F, The Burrow, 212 Choi Hung Road, San Po Kong, Kowloon

[email protected]

+852 3565 0938

Copyright © 2025 NutrigeneAI Biotech Limited | Powered by NutrigeneAI Biotech Limited